Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C
10.3892/or.2011.1305
Saved in:
Main Authors: | Bougen, N.M., Yang, T., Chen, H., Lobie, P.E., Perry, J.K. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/109208 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis
by: Zhu, Z., et al.
Published: (2016) -
The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells
by: Hou, L., et al.
Published: (2014) -
Autocrine growth hormone (hGH) and chemotherapeutic drug resistance in mammary carcinoma cells
by: ZHU ZHE
Published: (2010) -
Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells
by: Bougen, N.M., et al.
Published: (2014) -
THE ROLE OF TREFOIL FACTOR 3 IN MAMMARY CARCINOMA ANGIOGENESIS
by: LAU WAI HOE
Published: (2015)